Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 375 entries
View as:

Diet, ExerCIse and carDiovascular hEalth (DECIDE) - Salt Reduction Strategies for the Elderly in Nursing Homes in China

Phase: N/A Priority: Normal
NCT ID: NCT03290716 Org: User:
Start: 09/25/17 End: 05/11/21 Due: 05/11/22

A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00477711 Org: User:
Start: 03/31/07 End: 02/28/09 Due: 02/28/10

MC-19PD1 CAR-T in Relapsed or Refractory B Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03932955 Org: User:
Start: 05/01/19 End: 05/01/21 Due: 05/01/22

The Transformation of Locally Advanced Pancreatic Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT04723030 Org: User:
Start: 04/01/21 End: 04/01/23 Due: 04/01/24

Dexmedetomidine to Prevent Agitation After Free Flap Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01904760 Org: User:
Start: 06/30/13 End: - Due: -

Study of JS001 in Patients With Advanced Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03167853 Org: User:
Start: 04/06/17 End: 05/11/19 Due: 05/11/20

Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 1)

Phase: N/A Priority: Normal
NCT ID: NCT05194033 Org: User:
Start: 03/09/22 End: 05/19/22 Due: 05/19/23

Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT01339286 Org: User:
Start: 03/31/11 End: - Due: -

To Compare the Efficacy of Surgery Followed by Sunitinib With Surgery Followed by Imatinib in GIST Patients With Progression on Imatinib.

Phase: N/A Priority: Normal
NCT ID: NCT03424876 Org: User:
Start: 06/02/17 End: 08/08/18 Due: 08/08/19

Prospectively Predict the Efficacy and Explore the Mechanism of Treatment of Gastrointestinal Tumors Based on Peripheral Multi-omics Liquid Biopsy

Phase: N/A Priority: Normal
NCT ID: NCT05427227 Org: User:
Start: 07/01/22 End: 07/01/25 Due: 07/01/26

Prediction of Intra-abdominal Infectious Complication by Drainage Fluid Analysis

Phase: N/A Priority: Normal
NCT ID: NCT03862378 Org: User:
Start: 01/01/19 End: 12/31/21 Due: 12/31/22

IPO-NEC Trial:Study on the Efficacy and Safety Using Sequential IP Therapy and Oct Lar in the Treatment of Advanced GI NEC

Phase: N/A Priority: Normal
NCT ID: NCT01480986 Org: User:
Start: 09/30/11 End: 12/31/13 Due: 12/31/14

Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05393986 Org: User:
Start: 08/04/22 End: 12/30/24 Due: 12/30/25

A Diagnosis and Treatment Optimization Study of Depression Based on the Neurological Mechanism of Reward System

Phase: N/A Priority: Normal
NCT ID: NCT03148522 Org: User:
Start: 06/01/17 End: 06/30/22 Due: 06/30/23

Systemic Management in Extremely Preterm and Extremely Low Birth Weight Infants

Phase: N/A Priority: Normal
NCT ID: NCT06082414 Org: User:
Start: 01/30/19 End: 01/29/20 Due: 01/29/21

Afatinib Plus Toripalimab in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification

Phase: N/A Priority: Normal
NCT ID: NCT04880811 Org: User:
Start: 07/31/21 End: 05/31/23 Due: 05/31/24

The Effectiveness of Group-Delivered Guided Written Exposure Therapy for CPTSD Symptoms Among Adolescents : A Multi-centered Randomized Controlled Trail

Phase: N/A Priority: Normal
NCT ID: NCT06931093 Org: User:
Start: 04/10/25 End: 04/10/26 Due: 04/10/27

UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05775666 Org: User:
Start: 03/31/23 End: 01/31/25 Due: 01/31/26

A Study of Diagnosis and Treatment of Depression Based on Biological Evidence of Dopamine Reward Pathway

Phase: N/A Priority: Normal
NCT ID: NCT03148509 Org: User:
Start: 06/01/17 End: 12/30/19 Due: 12/30/20

The Efficacy and Safety of PEG-rhG-CSF（Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02944604 Org: User:
Start: 09/08/16 End: 09/30/17 Due: 09/30/18

Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT

Phase: N/A Priority: Normal
NCT ID: NCT00460330 Org: User:
Start: 04/30/07 End: 12/31/08 Due: 12/31/09

Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01336049 Org: User:
Start: 03/31/11 End: - Due: -

G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response

Phase: N/A Priority: Normal
NCT ID: NCT00397423 Org: User:
Start: 12/31/06 End: 08/31/07 Due: 08/31/08

Clinical Evaluation of Two Types of Transalveolar Sinus Floor Elevation

Phase: N/A Priority: Normal
NCT ID: NCT03445039 Org: User:
Start: 12/02/17 End: 12/25/20 Due: 12/25/21

Glaucoma Assessment Via Reading Ability

Phase: N/A Priority: Normal
NCT ID: NCT05673954 Org: User:
Start: 01/01/23 End: 02/29/24 Due: 02/28/25